Our office offers clinical trials in the field of gynecologic oncology. Both Dr. Indermaur and Dr. LaPolla offer studies to patients who qualify for a trial. All of our studies are National studies recognized by National Cancer Institute (NCI) of the National Institutes for Health (NIH). Most of the studies we offer are large multi-institute studies organized by the Gynecological Oncology Group (GOG).
Clinical trials that we are currently Enrolling patients at Women's Cancer Associates are:
Ovarian Cancer Studies
GOG 212 - Phase III Trial - Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
GOG 213 - Phase III trial - Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
GOG 262 - Phase III trial - Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV suboptimally debulked Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
GOG 258 – Phase III trial - Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
GOG 249 - Phase III trial - Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
We are constantly adding new trials so please inquire with either physician.
© 2012-2017 Women’s Care Florida. All Rights Reserved. All other trademarks are the property of their respective owners.